Niagen Bioscience, Inc. (NAGE)
6.53
-0.10
(-1.51%)
USD |
NASDAQ |
Dec 12, 16:00
6.53
0.00 (0.00%)
After-Hours: 20:00
Niagen Bioscience Total Assets (Quarterly): 98.14M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| TransMedics Group, Inc. | 946.03M |
| Liquidia Corp. | 275.98M |
| Recursion Pharmaceuticals, Inc. | 1.400B |
| Caris Life Sciences, Inc. | 984.57M |
| CEL-SCI Corp. | 20.34M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.46M |
| Shareholders Equity (Quarterly) | 70.68M |
| Debt to Equity Ratio | 0.0432 |
| Current Ratio | 4.122 |
| Net Debt Paydown Yield | 0.00% |